Zdrowie i gospodarka · 16/03/2021

FDA Reopens Comment Period for Orange Book Patent Information Listing

The FDA is reopening the comment period for a notice related to the listing of patent information in the Orange Book, a publication that tracks approved drugs, following the passage of the Orange Book Transparency Act in 2021.